Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair

Overview of attention for article published in Arthritis Research & Therapy, September 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 3 patents

Readers on

mendeley: 48 Mendeley

Summary Patents

So far, Altmetric has seen 3 patents that reference this research output.

A BIOACTIVE MATERIAL FOR THE REGENERATION OF CARTILAGE AND A PROCESS FOR THE OBTAINMENT…

Application WO-2013179209-A1

World Intellectual Property Organisation (WIPO)

MATERIALE BIOATTIVO PER LA RIGENERAZIONE DELLA CARTILAGINE E PROCEDIMENTO PER L'OTTENIMENTO…

Application IT-RM20120246-A1

Italy

THERAPEUTIC OR PROPHYLACTIC AGENT FOR OSTEOARTHRITIS

Application WO-2012144376-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.